Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 776-782 , October 2011

High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons

  • R. Molino-Lova

      Affiliations

    • Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Florence, Italy
    • Dept. Cardiopulmonary Rehabilitation, Don Gnocchi Foundation, Massa, Italy
    • Corresponding Author InformationCorresponding author. Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Via Imprunetana 124, 50020 Pozzolatico, Florence, Italy. Tel.: +39 055 2601 024; fax: +39 055 2601 256.
    • ,
  • C. Macchi

      Affiliations

    • Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Florence, Italy
    • Dept. of Medical and Surgical Critical Care, University of Florence, Florence, Italy
    • ,
  • A.M. Gori

      Affiliations

    • Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Florence, Italy
    • Dept. of Medical and Surgical Critical Care, Centre for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies (DeNOTHE), University of Florence, Florence, Italy
    • ,
  • R. Marcucci

      Affiliations

    • Dept. of Medical and Surgical Critical Care, Centre for the Study at Molecular and Clinical Level of Chronic, Degenerative and Neoplastic Diseases to Develop Novel Therapies (DeNOTHE), University of Florence, Florence, Italy
    • ,
  • P. Polcaro

      Affiliations

    • Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Florence, Italy
    • ,
  • F. Cecchi

      Affiliations

    • Dept. Cardiovascular Rehabilitation, Don Gnocchi Foundation, Florence, Italy
    • ,
  • F. Lauretani

      Affiliations

    • Tuscany Health Regional Agency, Florence, Italy
    • ,
  • S. Bandinelli

      Affiliations

    • Geriatric Rehabilitation Unit, ASF, Florence, Italy
    • ,
  • R. Abbate

      Affiliations

    • Dept. of Medical and Surgical Critical Care, University of Florence, Florence, Italy
    • ,
  • E. Beghi

      Affiliations

    • Laboratory of Neurological Disorders, Institute for Pharmacological Research Mario Negri, Milan, Italy
    • ,
  • J.M. Guralnik

      Affiliations

    • Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, MD, USA
    • ,
  • L. Ferrucci

      Affiliations

    • Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA

Received 4 November 2009 ,Revised 25 January 2010 ,Accepted 1 February 2010.

References 

  1. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129–2138
  2. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–619
  3. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118:2243–22514 pp.
  4. Ridker PM. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin Chem. 2008;54:234–237
  5. Ridker PM, Danielson E, Fonseca FA, Genest J, Giotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207
  6. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 2001;104:63–67
  7. Van der Meer I, De Maat MP, Hak AE, Kiliaan AJ, Del Sol AI, Van der Kuip DA, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke. 2002;33:2750–2755
  8. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke. 2004;35:1625–1630
  9. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, et al. Inflammation and Carotid Artery–Risk for Atherosclerosis Study (ICARAS). Circulation. 2005;111:2203–2209
  10. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. C-reactive protein predicts carotid atherosclerosis progression in mild to moderate risk and middle-aged patients. Clin Invest Med. 2006;29:77–82
  11. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis. 2007;195:e195–e202
  12. Arthurs ZM, Andersen C, Starnes BW, Sohn VY, Mullenix PS, Perry J. A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. J Vasc Surg. 2008;47:744–750
  13. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004;35:1619–1624
  14. Hee CS, Chang KH, Woo AC, Soo CB, Chung YS, Woo LK, et al. Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?. Eur J Cardiovasc Prev Rehabil. 2005;12:548–554
  15. Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005;36:2138–2142
  16. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke. 2006;37:351–357
  17. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke. 2007;38:1774–1779
  18. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134:250–256
  19. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225–231
  20. Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS. Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke. 2004;35:2150–2154
  21. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  22. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2–10
  23. Libby P, Ridker P. Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol. 2006;48:A33–A46
  24. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  25. Lucas AR, Korol R, Pepine CJ. Inflammation in atherosclerosis: some thoughts about acute coronary syndromes. Circulation. 2006;113:e728–e732
  26. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48:1618–1625
  27. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437
  28. Van Damme H, Vivario M. Pathologic aspects of carotid plaques: surgical and clinical significance. Int Angiol. 1993;12:299–311
  29. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294–2299
  30. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498–S504
  31. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  32. Johnsen SH, Fosse E, Joakimsen O, Mathiesen EB, Stensland-Bugge E, Njolstad I, et al. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromso Study. Stroke. 2005;36:715–719
  33. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481–1492
  34. Van der Meer I, Iglesias DS, Hak AE, Bots ML, Hofman A, Witteman JC. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke. 2003;34:2374–2379
  35. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386–1392
  36. Yasojima K, Schwab C, McGeer EG, McGeer Pl. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158:1039–1051
  37. Moshage HJ, Roelofs HM, van Pelt JF, Hazenberg BP, van Leeuwen MA, Limburg PC, et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun. 1988;155:112–117
  38. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108:1930–1932
  39. Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation. 2003;108:1428–1431

PII: S0939-4753(10)00038-4

doi: 10.1016/j.numecd.2010.02.003

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 776-782 , October 2011

Article Tools